Video

A quest for a cure: AI drug design with Isomorphic Labs

June 5, 2025
 min Read
 min Read
 min Read
 min Read
47
 min listen
47
 min watch
In this episode, host Hannah Fry is joined by our Head of Medicinal Chemistry, Rebecca Paul and our Chief AI Officer, Max Jaderberg, to explore the future of drug discovery in the age of AI. They discuss how new technology, including AlphaFold 3, is revolutionising the field by predicting the structure of life’s molecules, paving the way for faster and more efficient drug discovery.

They dig into the immense complexities of designing new drugs, considering questions such as:
How do you find the right molecular key for the right biological lock? How can AI help scientists understand disease better and overcome challenges like drug toxicity? And what about the diseases that are currently considered “undruggable”? Finally, they explore the ultimate impact of this technology, from the future of personalised medicine to the ambitious goal of being able to eventually design treatments for all diseases.